Ahmet Doǧan

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Genomic features do not account for differences in multiple myeloma risk by ancestry

  Blood Cancer Discovery · 2026-06-12

• Expanded germline genetic testing of patients with hematologic malignancies to identify high proportion with hereditary cancer predisposition.

  Journal of Clinical Oncology · 2026-05-27

• Deployment of AI-driven automated quality control of whole-slide images in a large tertiary cancer center

  Journal of Pathology Informatics · 2026-05-15

• Ecological determinants of disease and immunity in myelodysplastic syndromes

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-05-09

• Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource Committee

  Journal of the National Comprehensive Cancer Network · 2026-04-27

• SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities

  Cancer Discovery · 2026-04-21

• Accurate automated diagnosis of B-acute lymphoblastic leukemia using deep learning and flow cytometry

  Haematologica · 2026-01-08

• Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay

  Molecular & Cellular Proteomics · 2025-12-12 · 1 citations

• CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

  Blood · 2025-12-10 · 4 citations

• Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas

  Haematologica · 2025-11-27 · 1 citations

• Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

  Haematologica · 2025-11-27 · 1 citations

• Supplementary Table S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• AI-based diagnosis of cutaneous lymphoma and lymphoproliferative disorders via H&E morphology and LLM-assisted cohort curation

  Blood · 2025-11-03

• Outcomes of patients (Pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) progressing after CD3xCD20 bispecific antibody (BsAb) therapy: A new unmet need

  Blood · 2025-11-03

• Image-based classification of lymphocyte subsets from routine blood smears reveals distinct immune dynamics after CAR-T infusion

  Blood · 2025-11-03

• Efficacy and safety of zanubrutinib in patients with non-IgM lymphoplasmacytic lymphoma

  Blood · 2025-11-03

• Are all GELF criteria created equal? utility of individual GELF criteria as guidance for treatment initiation in patients with advanced stage FL

  Blood · 2025-11-03 · 1 citations

• Anti-CD94 monoclonal antibody DR-01 induced response in a refractory primary CNS T-cell lymphoma

  Blood · 2025-11-03